| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Berberine | Acute Liver Failure | 1 | PM | 29191769 | 📋 | Berberine protects acute liver failure in mice through inhibiting inflammation and mitochondria-dependent apoptosis |
| Berberine | Acute Liver Injury | 1 | PM | 31432116 | 📋 | Berberine Ameliorates CCl4‑induced Liver Injury in Rats Through Regulation of the Nrf2‑Keap1‑ARE and p53 Signaling Pathways |
| Berberine | Alcoholic Liver Disease | 2 | PM | 36870291 | 📋 | Berberine Ameliorates Abnormal Lipid Metabolism via the Adenosine Monophosphate-Activated Protein Kinase/Sirtuin 1 Pathway in Alcohol-Related Liver Disease |
| Berberine | Alcoholic Liver Disease | 1 | PM | 32790968 | 📋 | Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease |
| Berberine | Autoimmune Hepatitis | 2 | PM | 38466881 | 📋 | Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota |
| Berberine | Autoimmune Hepatitis | 1 | PM | 29283990 | 📋 | The Effects of Berberine on Concanavalin A-Induced Autoimmune Hepatitis (AIH) in Mice and the Adenosine 5'-Monophosphate (AMP)-Activated Protein Kinase (AMPK) Pathway |
| Berberine | Biliary Tract Cancer | 2 | PM | 36308362 | 📋 | Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor |
| Berberine | Biliary Tract Cancer | 1 | PM | 28566619 | 📋 | Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-κB and STAT3 Pathways |
| Berberine | Hepatic Encephalopathy | 1 | PM | 37371422 | 📋 | Effect of Berberine against Cognitive Deficits in Rat Model of Thioacetamide-Induced Liver Cirrhosis and Hepatic Encephalopathy (Behavioral, Biochemical, Molecular and Histological Evaluations) |
| Berberine | Hepatic Fibrosis | 5 | PM | 37062521 | 📋 | Berberine attenuates liver fibrosis by autophagy inhibition triggering apoptosis via the miR-30a-5p/ATG5 axis |
| Berberine | Hepatic Fibrosis | 4 | PM | 35308208 | 📋 | Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora |
| Berberine | Hepatic Fibrosis | 2 | PM | 34864819 | 📋 | Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis |
| Berberine | Hepatic Fibrosis | 1 | PM | 30138605 | 📋 | Antioxidant and Anti-Inflammatory Activities of Berberine Attenuate Hepatic Fibrosis Induced by Thioacetamide Injection in Rats |
| Berberine | Hepatic Fibrosis | 6 | PM | 23734997 | 📋 | Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl₄-intoxicated mice is mediated by suppression of oxidative stress and upregulation of MMP-2 expression |
| Berberine | Hepatic Fibrosis | 7 | PM | 23190573 | 📋 | A comparative study on the hepatoprotective action of bear bile and Coptidis Rhizoma aqueous extract on experimental liver fibrosis in rats |
| Berberine | Hepatic Fibrosis | 3 | PM | 19721228 | 📋 | Berberine Inhibits Hepatic Stellate Cell Proliferation and Prevents Experimental Liver Fibrosis |
| Berberine | Hepatic Ischemia-Reperfusion | 1 | PM | 37780378 | 📋 | Berberine protects hepatocyte from hypoxia/reoxygenation-induced injury through inhibiting circDNTTIP2 |
| Berberine | Hepatic Steatosis | 4 | PM | 35722423 | 📋 | Methyltransferase SETD2 mediates hepatoprotection of berberine against steatosis |
| Berberine | Hepatic Steatosis | 3 | PM | 34790723 | 📋 | Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE -/- mice by down-regulating PCSK9 via ERK1/2 pathway |
| Berberine | Hepatic Steatosis | 2 | PM | 29477657 | 📋 | Berberine Induces miR-373 Expression in Hepatocytes to Inactivate Hepatic Steatosis Associated AKT-S6 Kinase Pathway |
| Berberine | Hepatic Steatosis | 1 | PM | 29065221 | 📋 | Berberine Attenuates Hepatic Steatosis and Enhances Energy Expenditure in Mice by Inducing Autophagy and Fibroblast Growth Factor 21 |
| Berberine | Hepatic Steatosis | 5 | PM | 28900305 | 📋 | Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells |
| Berberine | Hepatitis C | 1 | PM | 32276448 | 📋 | Targeting Autophagy Augments BBR-Mediated Cell Death in Human Hepatoma Cells Harboring Hepatitis C Virus RNA |
| Berberine | Hepatotoxicity | 11 | PM | 38633147 | 📋 | Ameliorative effects of berberine and selenium against paracetamol-induced hepatic toxicity in rats |
| Berberine | Hepatotoxicity | 10 | PM | 37421530 | 📋 | Berberine mitigates acetamiprid-induced hepatotoxicity and inflammation via regulating endogenous antioxidants and NF-κB/TNF-α signaling in rats |
| Berberine | Hepatotoxicity | 7 | PM | 36655525 | 📋 | Evaluation of the Antioxidant Effects of Berberine against Sodium Nitrite-induced Oxidative Injury in the Rat Liver |
| Berberine | Hepatotoxicity | 6 | PM | 35427583 | 📋 | Berberis integerrima hydro-alcoholic root extract ant its constituent berberine protect against cisplatin-induced nephro- and hepato-toxicity |
| Berberine | Hepatotoxicity | 5 | PM | 34979291 | 📋 | Berberine improves liver injury induced glucose and lipid metabolic disorders via alleviating ER stress of hepatocytes and modulating gut microbiota in mice |
| Berberine | Hepatotoxicity | 2 | PM | 34258700 | 📋 | Hepatoprotective effects of phytochemicals berberine and umbelliferone against methotrexate-induced hepatic intoxication: experimental studies and in silico evidence |
| Berberine | Hepatotoxicity | 3 | PM | 31845254 | 📋 | Hepatoprotective Role of Berberine Against Paraquat-Induced Liver Toxicity in Rat |
| Berberine | Hepatotoxicity | 1 | PM | 29864914 | 📋 | Hepatoprotective Effects of Berberine on Acetaminophen-Induced Hepatotoxicity in Mice |
| Berberine | Hepatotoxicity | 9 | PM | 29091871 | 📋 | Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats |
| Berberine | Hepatotoxicity | 8 | PM | 28763751 | 📋 | Berberine ameliorates methotrexate-induced liver injury by activating Nrf2/HO-1 pathway and PPARγ, and suppressing oxidative stress and apoptosis in rats |
| Berberine | Hepatotoxicity | 4 | PM | 11449466 | 📋 | Studies on Preventive and Curative Effects of Berberine on Chemical-Induced Hepatotoxicity in Rodents |
| Berberine | Liver Cancer | 34 | PM | 38750718 | 📋 | Berberine increases the killing effect of pirarubicin on HCC cells by inhibiting ATG4B-autophagy pathway |
| Berberine | Liver Cancer | 33 | PM | 38693042 | 📋 | The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH |
| Berberine | Liver Cancer | 32 | PM | 38301771 | 📋 | Berberine prevents NAFLD and HCC by modulating metabolic disorders |
| Berberine | Liver Cancer | 31 | PM | 38084140 | 📋 | Inhibition of hepatocellular carcinoma growth via modulation of the miR-221/SOX11 axis by curcumin and berberine |
| Berberine | Liver Cancer | 25 | PM | 37148713 | 📋 | Berberine activates PPARδ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma |
| Berberine | Liver Cancer | 24 | PM | 36191360 | 📋 | Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine |
| Berberine | Liver Cancer | 23 | PM | 36090480 | 📋 | Berberine inhibits carcinogenesis through antagonizing the ATX-LPA-LPAR2-p38-leptin axis in a mouse hepatoma model |
| Berberine | Liver Cancer | 22 | PM | 34787617 | 📋 | Antiproliferative activity of berberine in HepG2 cells via inducing apoptosis and arresting cell cycle |
| Berberine | Liver Cancer | 21 | PM | 34712379 | 📋 | Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF β R Regulating TGF- β/Smad Pathway |
| Berberine | Liver Cancer | 20 | PM | 34460138 | 📋 | A novel combined resveratrol/berberine phytochemotheraputic using the HePG2 cell line as a model for the treatment of hepatocarcinoma |
| Berberine | Liver Cancer | 19 | PM | 34395446 | 📋 | Probing Synergistic Targets by Natural Compounds for Hepatocellular Carcinoma |
| Berberine | Liver Cancer | 18 | PM | 34220494 | 📋 | Berberine Sensitizes Human Hepatoma Cells to Regorafenib via Modulating Expression of Circular RNAs |
| Berberine | Liver Cancer | 17 | PM | 33130557 | 📋 | Berberine represses β-catenin translation involving 4E-BPs in hepatocellular carcinoma cells |
| Berberine | Liver Cancer | 29 | PM | 32815562 | 📋 | Berberine, a natural alkaloid sensitizes human hepatocarcinoma to ionizing radiation by blocking autophagy and cell cycle arrest resulting in senescence |
| Berberine | Liver Cancer | 16 | PM | 32606742 | 📋 | Berberine Inhibits the Apoptosis-Induced Metastasis by Suppressing the iPLA2/LOX-5/LTB4 Pathway in Hepatocellular Carcinoma |
| Berberine | Liver Cancer | 15 | PM | 32276448 | 📋 | Targeting Autophagy Augments BBR-Mediated Cell Death in Human Hepatoma Cells Harboring Hepatitis C Virus RNA |
| Berberine | Liver Cancer | 2 | PM | 32021249 | 📋 | Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake |
| Berberine | Liver Cancer | 11 | PM | 31545468 | 📋 | Exploring the Active Mechanism of Berberine Against HCC by Systematic Pharmacology and Experimental Validation |
| Berberine | Liver Cancer | 4 | PM | 31217846 | 📋 | Berberine Prevents Non-Alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma by Inhibiting Inflammation and Angiogenesis in Mice |
| Berberine | Liver Cancer | 3 | PM | 30565332 | 📋 | Synergistic Effect of Berberine and HMQ1611 Impairs Cell Proliferation and Migration by Regulating Wnt Signaling Pathway in Hepatocellular Carcinoma |
| Berberine | Liver Cancer | 10 | PM | 30015938 | 📋 | Berberine, a Natural Plant Alkaloid, Synergistically Sensitizes Human Liver Cancer Cells to Sorafenib |
| Berberine | Liver Cancer | 6 | PM | 29626488 | 📋 | Berberine Induced Modulation of PHLPP2-Akt-MST1 Kinase Signaling Is Coupled With Mitochondrial Impairment and Hepatoma Cell Death |
| Berberine | Liver Cancer | 5 | PM | 29360760 | 📋 | Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells |
| Berberine | Liver Cancer | 7 | PM | 28572744 | 📋 | Berberine Regulates the Protein Expression of Multiple Tumorigenesis-Related Genes in Hepatocellular Carcinoma Cell Lines |
| Berberine | Liver Cancer | 8 | PM | 28277195 | 📋 | Induction of Apoptosis by Berberine in Hepatocellular Carcinoma HepG2 Cells via Downregulation of NF-κB |
| Berberine | Liver Cancer | 14 | PM | 27854312 | 📋 | Berberine Suppresses Cyclin D1 Expression Through Proteasomal Degradation in Human Hepatoma Cells |
| Berberine | Liver Cancer | 9 | PM | 27311637 | 📋 | Antiproliferation of Berberine Is Mediated by Epigenetic Modification of Constitutive Androstane Receptor (CAR) Metabolic Pathway in Hepatoma Cells |
| Berberine | Liver Cancer | 13 | PM | 27092498 | 📋 | Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine |
| Berberine | Liver Cancer | 28 | PM | 23999088 | 📋 | Berberine and S allyl cysteine mediated amelioration of DEN+CCl4 induced hepatocarcinoma |
| Berberine | Liver Cancer | 27 | PM | 23784371 | 📋 | Berberine induces apoptosis via the mitochondrial pathway in liver cancer cells |
| Berberine | Liver Cancer | 26 | PM | 23732865 | 📋 | Berberine induces selective apoptosis through the AMPK‑mediated mitochondrial/caspase pathway in hepatocellular carcinoma |
| Berberine | Liver Cancer | 30 | PM | 21443647 | 📋 | Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147 |
| Berberine | Liver Cancer | 12 | PM | 19724899 | 📋 | Coptis Chinensis Inhibits Hepatocellular Carcinoma Cell Growth Through Nonsteroidal Anti-Inflammatory Drug-Activated Gene Activation |
| Berberine | Liver Cancer | 1 | PM | 19408145 | 📋 | Berbamine Induces Fas-mediated Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells and Inhibits Its Tumor Growth in Nude Mice |
| Berberine | Liver Damage | 1 | PM | 35436630 | 📋 | Hydrochloride Berberine ameliorates alcohol-induced liver injury by regulating inflammation and lipid metabolism |
| Berberine | Liver Damage | 6 | PM | 35078575 | 📋 | [Berberine hydrochloride attenuates liver injury induced by acute hypoxic exposure by inhibiting TNF-α/caspase-8/caspase-3 signaling pathway] |
| Berberine | Liver Disease | 4 | PM | 38693042 | 📋 | The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH |
| Berberine | Liver Disease | 3 | PM | 34056769 | 📋 | Molecular updates on berberine in liver diseases: Bench to bedside |
| Berberine | Liver Disease | 2 | PM | 33068590 | 📋 | The pharmacological activity of berberine, a review for liver protection |
| Berberine | Liver Disease | 1 | PM | 32265720 | 📋 | The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism |
| Berberine | MAFLD | 35 | PM | 38762210 | 📋 | Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD |
| Berberine | MAFLD | 34 | PM | 38723878 | 📋 | Berberine ameliorates nonalcoholic fatty liver disease-induced bone loss by inhibiting ferroptosis |
| Berberine | MAFLD | 33 | PM | 38673787 | 📋 | Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature |
| Berberine | MAFLD | 32 | PM | 38429794 | 📋 | The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review |
| Berberine | MAFLD | 31 | PM | 38301771 | 📋 | Berberine prevents NAFLD and HCC by modulating metabolic disorders |
| Berberine | MAFLD | 28 | PM | 37293270 | 📋 | Berberine alleviates non-alcoholic hepatic steatosis partially by promoting SIRT1 deacetylation of CPT1A in mice |
| Berberine | MAFLD | 27 | PM | 36838862 | 📋 | Berberine Ameliorates Metabolic-Associated Fatty Liver Disease Mediated Metabolism Disorder and Redox Homeostasis by Upregulating Clock Genes: Clock and Bmal1 Expressions |
| Berberine | MAFLD | 26 | PM | 36079717 | 📋 | Berberine in Non-Alcoholic Fatty Liver Disease-A Review |
| Berberine | MAFLD | 25 | PM | 35873595 | 📋 | Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota |
| Berberine | MAFLD | 24 | PM | 35726797 | 📋 | Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats |
| Berberine | MAFLD | 23 | PM | 35722423 | 📋 | Methyltransferase SETD2 mediates hepatoprotection of berberine against steatosis |
| Berberine | MAFLD | 22 | PM | 35584453 | 📋 | The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats |
| Berberine | MAFLD | 21 | PM | 35382695 | 📋 | Effect of berberine and bicyclol on Chinese patients with non-alcoholic fatty liver disease: a retrospective study |
| Berberine | MAFLD | 20 | PM | 35359076 | 📋 | [Berberine alleviates programmed necrosis of metabolic-associated fatty liver disease via activating Nrf2 pathway in mice] |
| Berberine | MAFLD | 19 | PM | 35250593 | 📋 | Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease |
| Berberine | MAFLD | 18 | PM | 34566663 | 📋 | Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies |
| Berberine | MAFLD | 17 | PM | 34504563 | 📋 | Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR |
| Berberine | MAFLD | 16 | PM | 34094026 | 📋 | The therapeutic effects of berberine plus sitagliptin in a rat model of fatty liver disease |
| Berberine | MAFLD | 15 | PM | 33831691 | 📋 | Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats |
| Berberine | MAFLD | 14 | PM | 33626003 | 📋 | Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway |
| Berberine | MAFLD | 13 | PM | 32429849 | 📋 | Anti-inflammatory Activity of Berberine in Non-Alcoholic Fatty Liver Disease via the Angptl2 Pathway |
| Berberine | MAFLD | 12 | PM | 32403887 | 📋 | [Discussion on the Curative Effect and Mechanisms of Berberine in Rats With Non-Alcoholic Fatty Liver] |
| Berberine | MAFLD | 11 | PM | 32357187 | 📋 | Berberine Inhibits Free Fatty Acid and LPS-induced Inflammation via Modulating ER Stress Response in Macrophages and Hepatocytes |
| Berberine | MAFLD | 1 | PM | 32194416 | 📋 | Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis |
| Berberine | MAFLD | 7 | PM | 31226399 | 📋 | Berberine Attenuates Nonalcoholic Hepatic Steatosis Through the AMPK-SREBP-1c-SCD1 Pathway |
| Berberine | MAFLD | 4 | PM | 30868489 | 📋 | Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway |
| Berberine | MAFLD | 6 | PM | 30867696 | 📋 | Berberine Attenuates Hepatic Oxidative Stress in Rats With Non-Alcoholic Fatty Liver Disease via the Nrf2/ARE Signalling Pathway |
| Berberine | MAFLD | 3 | PM | 30848932 | 📋 | Berberine Alleviates Nonalcoholic Fatty Liver Induced by a High-Fat Diet in Mice by Activating SIRT3 |
| Berberine | MAFLD | 2 | PM | 29505790 | 📋 | Berberine Alleviates Hepatic Lipid Accumulation by Increasing ABCA1 Through the Protein Kinase C δ Pathway |
| Berberine | MAFLD | 10 | PM | 29353208 | 📋 | Natural Products Berberine and Curcumin Exhibited Better Ameliorative Effects on Rats With Non-Alcohol Fatty Liver Disease Than Lovastatin |
| Berberine | MAFLD | 29 | PM | 29200733 | 📋 | Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats |
| Berberine | MAFLD | 8 | PM | 26936230 | 📋 | Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice With Diet-induced Obesity |
| Berberine | MAFLD | 9 | PM | 26857750 | 📋 | Berberine Prevents Progression From Hepatic Steatosis to Steatohepatitis and Fibrosis by Reducing Endoplasmic Reticulum Stress |
| Berberine | MAFLD | 5 | PM | 26252777 | 📋 | Efficacy of Berberine in Patients With Non-Alcoholic Fatty Liver Disease |
| Berberine | MAFLD | 30 | PM | 21839075 | 📋 | Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver |
| Berberine | Non-Alcoholic Steatohepatitis | 10 | PM | 37652508 | 📋 | Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis |
| Berberine | Non-Alcoholic Steatohepatitis | 9 | PM | 34686466 | 📋 | Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis |
| Berberine | Non-Alcoholic Steatohepatitis | 8 | PM | 34603061 | 📋 | Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation |
| Berberine | Non-Alcoholic Steatohepatitis | 7 | PM | 34566663 | 📋 | Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies |
| Berberine | Non-Alcoholic Steatohepatitis | 6 | PM | 33494295 | 📋 | Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways |
| Berberine | Non-Alcoholic Steatohepatitis | 5 | PM | 32524150 | 📋 | Berberine Attenuates Non-Alcoholic Steatohepatitis by Regulating chemerin/CMKLR1 Signalling Pathway and Treg/Th17 Ratio |
| Berberine | Non-Alcoholic Steatohepatitis | 2 | PM | 32194416 | 📋 | Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis |
| Berberine | Non-Alcoholic Steatohepatitis | 4 | PM | 31217846 | 📋 | Berberine Prevents Non-Alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma by Inhibiting Inflammation and Angiogenesis in Mice |
| Berberine | Non-Alcoholic Steatohepatitis | 3 | PM | 29075339 | 📋 | Berberine Ameliorates Non-Alcoholic Steatohepatitis in ApoE -/- Mice |
| Berberine | Non-Alcoholic Steatohepatitis | 1 | PM | 26923892 | 📋 | Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice |
| Berberine | Primary Sclerosing Cholangitis | 2 | PM | 38332450 | 📋 | Berberine ameliorates the progression of primary sclerosing cholangitis by activating farnesoid X receptor |
| Berberine | Primary Sclerosing Cholangitis | 1 | PM | 38273376 | 📋 | Therapeutic potential of berberine in attenuating cholestatic liver injury: insights from a PSC mouse model |
